Open AccessResults of a multicenter double-blind phase I clinical trial of using of BCD-022 compared with Herceptin, used in combination with paclitaxel in patients with metastatic breast cancer
Author(s) -
Ekaterina Ignatova,
М. А. Фролова,
Olga Burdaeva,
M. Nechaeva,
А. П. Печеный,
Mikhail V. Kopp,
Dmitry Udovitsa,
Б. Н. Котив,
В. А. Чубенко,
Д. Л. Строяковский,
Ludmila P. Sheveleva,
Andrey V. Khorinko,
Tatiana I. Prokopenko,
Ю. С. Шаповалова,
Ю А Жевлакова
Publication year - 2015
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2014-4-62-70
Subject(s) - paclitaxel , medicine , oncology , metastatic breast cancer , clinical trial , double blind , breast cancer , multicenter study , phases of clinical research , cancer , randomized controlled trial , pathology , alternative medicine , placebo